Capricor Therapeutics, Inc.
CAPR
$6.38
-$0.22-3.33%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.23% | -242.74% | 43.32% | -14.15% | -12.31% |
| Total Depreciation and Amortization | 19.93% | 7.93% | 4.01% | 1.20% | 7.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -38.19% | 145.51% | 17.24% | -4.77% | -34.18% |
| Change in Net Operating Assets | -85.68% | 211.79% | -602.36% | 60.73% | -176.70% |
| Cash from Operations | -212.77% | 56.52% | -27.09% | 5.26% | -868.82% |
| Capital Expenditure | -27.13% | -55.21% | -1,145.25% | 27.07% | 87.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -36.08% | 120.41% | -6,043.06% | -86.03% | 267.19% |
| Cash from Investing | -39.10% | 119.36% | -6,254.92% | -86.36% | 254.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -61.11% | -99.94% | 20.44% | 3,157.07% | -9.74% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -61.11% | -99.94% | 20.44% | 3,157.07% | -9.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -131.72% | 130.67% | -198.96% | 1,189.51% | 152.75% |